Meeting
2022 ASCO Quality Care Symposium
Improving documentation of zoledronic acid interval in ambulatory oncology patients.
Authors
Tanvi Dandawate
Dana-Farber Cancer Institute, Boston, MA
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Patient Safety
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 323)
DOI
10.1200/JCO.2022.40.28_suppl.323
Abstract #
323
Poster Bd #
C30
Abstract Disclosures
Similar Posters
First Author: Nicholas Rinaldi
Poster
2023 ASCO Annual Meeting
Mapping objectives of a new interprofessional morbidity and mortality conference to ACGME core competencies in hematology/oncology.
First Author: Aditya Sharma
First Author: Katie Magni
Poster
2017 ASCO Quality Care Symposium
Improving cancer treatment handoffs: Wilmot Cancer Institute’s (WCI) ASCO Quality Training Program experience.
First Author: David W. Dougherty